The ROE as of November 2024 (TTM) for U.S. Stem Cell, Inc. (USRM) is 15.39%

According to U.S. Stem Cell, Inc.’s latest financial reports and current stock price. The company's current ROE is 15.39%. This represents a change of 1.50% compared to the average of 0.96% of the last 4 quarters.

U.S. Stem Cell, Inc. (USRM) Historical ROE (quarterly & annually)

How has USRM ROE performed in the past?

The mean historical ROE of U.S. Stem Cell, Inc. over the last ten years is 30.94%. The current 15.39% ROE has changed -50.25% with respect to the historical average. Over the past ten years (40 quarters), USRM's ROE was at its highest in in the March 2017 quarter at 32.89%. The ROE was at its lowest in in the June 2015 quarter at -9.68%.

U.S. Stem Cell, Inc. (USRM) ROE by Quarter and Year

Discovering the peaks and valleys of U.S. Stem Cell, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

U.S. Stem Cell, Inc. (USRM) Average ROE

How has USRM ROE performed in the past?

The current ROE of U.S. Stem Cell, Inc. (USRM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

U.S. Stem Cell, Inc. (USRM) ROE vs. Peers

How is USRM’s ROE compared to its peers?

U.S. Stem Cell, Inc.’s ROE is less than Adhera Therapeutics, Inc. (13.30%), less than AgeX Therapeutics, Inc. (172.71%), greater than XOMA Corporation (-19.34%), greater than Lineage Cell Therapeutics, Inc. (-35.54%), less than Nascent Biotech, Inc. (1.03%), greater than ProtoKinetix, Incorporated (-87.94%), less than RespireRx Pharmaceuticals Inc. (8.92%), greater than Silo Pharma, Inc. (-56.41%), less than VG Life Sciences Inc. (2.26%), greater than PharmaTher Holdings Ltd. (-102.91%), less than Regen BioPharma, Inc. (16.82%), less than Regen BioPharma, Inc. (16.82%), less than Mymetics Corporation (15.72%), greater than Theralink Technologies, Inc. (-41.95%), less than GB Sciences, Inc. (0%), less than SciSparc Ltd. (27.88%), greater than null (-87.48%),

Build a custom stock screener for U.S. Stem Cell, Inc. (USRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like U.S. Stem Cell, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

U.S. Stem Cell, Inc. (USRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like U.S. Stem Cell, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.